NCT00025467 · Interventional trial
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer
Overall registry status Completed
Phase 2
Conditions Endometrial Adenoacanthoma, Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma
Delaware Valley sites
- Gynecologic Oncology Group · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory